MSNBC Katy Tur Reports September 20, 2021 18:01:00
Approval for younger kids can't come soon enough. for elementary school aged kids, pfizer tested a much lower vaccine dose. a third of the amount that's in shots for teens and adults. but doctors say that low dose in kids produced the same strong levels of antibodies with fewer side effects. pfizer says it plans to seek u.s. authorization by the end of the month. and once it does, the data will have to be examined by the fda and the cdc. and the timing appears to be in line with what dr. fauci said, his prediction of shots by late fall or early winter. >> so the company wanted to find a dose t...